Common use of No Harmful Actions Clause in Contracts

No Harmful Actions. If a Party believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such Product in the first Party’s territory, then such Party may bring the matter to the attention of the JDC and the Parties shall discuss in good faith to resolve such concern.

Appears in 6 contracts

Samples: Collaboration and License Agreement (Exelixis, Inc.), Collaboration and License Agreement (Exelixis, Inc.), Collaboration and License Agreement (Exelixis, Inc.)

AutoNDA by SimpleDocs

No Harmful Actions. If a either Party believes that the other Party Party, as the case may be, is taking or intends to take any action with respect to a the Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such the Product in the first Party’s territoryRetained Territory or the Licensed Territory, then such Party may shall have the right to bring the matter to the attention of the JDC and the Parties shall discuss in good faith to resolve such concernJDC.

Appears in 3 contracts

Samples: License and Collaboration Agreement (Five Prime Therapeutics Inc), License and Collaboration Agreement (Five Prime Therapeutics Inc), License and Collaboration Agreement (Five Prime Therapeutics Inc)

No Harmful Actions. If a Party reasonably believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such Product in the first Party’s territory, then such Party may bring the matter to the attention of the JDC JSC and the Parties shall discuss in good faith to promptly resolve such concern.

Appears in 2 contracts

Samples: License Agreement (Rigel Pharmaceuticals Inc), Collaboration and License Agreement (Rigel Pharmaceuticals Inc)

No Harmful Actions. If a either Party believes that the other Party Party, as the case may be, is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such Product in the first Party’s territoryProduct, then such Party may shall have the right to bring the matter to the attention of the JDC and the Parties shall discuss in good faith to resolve such concernJSC.

Appears in 2 contracts

Samples: Research Services Agreement (Dyadic International Inc), Research Services Agreement (Dyadic International Inc)

No Harmful Actions. If a Party believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status effect on obtaining or maintaining Regulatory Approval of such any Product in the first either Party’s territoryTerritory or Commercialization of any Product in either Party’s Territory, then such Party may bring the matter to the attention of the JDC Local JCCs and the Parties shall discuss in good faith to resolve such concern.

Appears in 1 contract

Samples: Collaboration and License Agreement (Aurinia Pharmaceuticals Inc.)

No Harmful Actions. If a Party believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such Product in the first Party’s territory, then such Party may bring the matter to the attention of the JDC and the Parties shall discuss in good faith to resolve such concern.. 5.7

Appears in 1 contract

Samples: Collaboration and License Agreement

No Harmful Actions. If a either Party believes that the other Party is taking or intends to take any action with respect to a any Licensed Product that could reasonably be expected to have a material adverse impact upon pose [***], as applicable, the regulatory status of such Product in the first Party’s territory, then such Party may bring the matter to the attention of the JDC JCC and the Parties shall discuss in good faith to promptly resolve such concern.

Appears in 1 contract

Samples: License Agreement (Keros Therapeutics, Inc.)

No Harmful Actions. If a Party reasonably believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such any Product in the first such Party’s territoryTerritory, then such Party may bring the matter to the attention of the JDC JSC and the Parties JSC shall discuss such concern in good faith to resolve such concernfaith.

Appears in 1 contract

Samples: License Agreement (ADC Therapeutics SA)

No Harmful Actions. If a Party reasonably believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such Product in the first such Party’s territory, then such Party may bring the matter to the attention of the JDC CGB and the Parties shall discuss in good faith to promptly resolve such concern.

Appears in 1 contract

Samples: Collaboration and License Agreement (Ovid Therapeutics Inc.)

AutoNDA by SimpleDocs

No Harmful Actions. If a Party reasonably believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status status, approval, labeling, safety, market clearance, or the ability of such Party to sell, market, Develop, or Commercialize any Product in the first such Party’s territoryTerritory, then such Party may bring the matter to the attention of the JDC JSC and the Parties JSC shall discuss such concern in good faith to resolve such concernfaith.

Appears in 1 contract

Samples: License Agreement (ADC Therapeutics SA)

No Harmful Actions. If a Party reasonably believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such any Product in the first such Party’s territoryTerritory, then such Party may bring the matter to the attention of the JDC JSC and the Parties shall discuss seek in good faith to promptly resolve such concern.

Appears in 1 contract

Samples: Exclusive License and Collaboration Agreement (Forty Seven, Inc.)

No Harmful Actions. If a either Party believes that the other Party is taking or intends to take any action with respect to a Product that could reasonably be expected to have a material adverse impact upon the regulatory status of such the Product in the first Party’s outside its respective territory, then such Party may has the right to bring the matter to the attention of the JDC and the Parties shall will discuss in good faith to resolve such concern.

Appears in 1 contract

Samples: License Agreement (Turning Point Therapeutics, Inc.)

No Harmful Actions. If a Party believes that the other Party is taking or intends to take any action with respect to a any Product that could reasonably be expected to have a material adverse impact upon the Development, Manufacture, Commercialization or regulatory status of such any Product in the first other Party’s territoryTerritory, then such the impacted Party may bring the matter to the attention of the JDC JSC and the Parties shall discuss in good faith to promptly resolve such concern.

Appears in 1 contract

Samples: Development and Manufacturing Collaboration Agreement (Vir Biotechnology, Inc.)

No Harmful Actions. If a Party believes that the other Party is taking or intends to take any action with respect to a any Product that could reasonably [*] be expected to have a material adverse impact upon the regulatory status of such the Product in the first Party’s its territory, then such Party may bring the matter to the attention of the JDC JSC and the Parties shall discuss in good faith [*] to [*] resolve such concern.

Appears in 1 contract

Samples: License and Collaboration Agreement (C4 Therapeutics, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.